Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care

NCT00950534 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped due to poor recruitment

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: INSULIN GLARGINE (HOE901)
DRUG: Oral Anti Diabetics (OAD)

Sponsor

Sanofi